Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
ESSA Pharma Inc. (EPIX) had Return on Tangible Equity of -5.61% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.37M |
|
-- |
|
-- |
|
$7.38M |
|
$-7.38M |
|
$1.01M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-7.38M |
|
$-7.36M |
|
44.39M |
|
44.39M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$115.17M |
|
-- |
|
$0.25M |
|
$115.42M |
|
$1.71M |
|
-- |
|
$0.15M |
|
$1.87M |
|
$113.55M |
|
$113.55M |
|
$113.55M |
|
44.39M |
|
| Cash Flow Statement Financials | |
$-13.32M |
|
$-4.08M |
|
-- |
|
$103.71M |
|
$86.31M |
|
$-17.40M |
|
$3.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
67.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.61% |
|
|
Return on Tangible Equity |
-5.61% |
-5.52% |
|
-5.61% |
|
$2.56 |
|
$-0.30 |
|
$-0.30 |
|